Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» sarcoma
sarcoma
Aadi clinches first FDA nod for ultrarare sarcoma drug Fyarro
Fierce Pharma
Tue, 11/23/21 - 08:54 pm
Aadi Bioscience
Fyarro
sarcoma
FDA
Adaptimmune’s ASCO data for cell therapy in sarcoma spark optimism about Phase II study potential
MedCity News
Tue, 06/2/20 - 10:20 am
Adaptimmune
ASCO 2020
cell therapy
sarcoma
ADP-A2M4
CytRx CEO Pockets Millions of Dollars as Failed Sarcoma Drug Moves to FDA
TheStreet.com
Tue, 11/29/16 - 09:54 am
CytRx
Pharma CEOs
aldoxorubicin
sarcoma
FDA
Speedy US review for J&J sarcoma drug Yondelis
Pharma Times
Tue, 02/3/15 - 11:31 am
JNJ
sarcoma
Yondelis
priority review
Zeltia
The Sirens of Ziopharm
Seeking Alpha
Mon, 06/16/14 - 07:37 am
sarcoma
oncology
Ziopharm
Northwest Biotherapeutics Reports On Sarcoma Patient Treated With DCVAx-Direct
Seeking Alpha
Thu, 05/15/14 - 11:04 am
Northwest Biotherapeutics
sarcoma
DCVax Direct
Richard Pearson Responds On Ziopharm
Seeking Alpha
Sat, 10/27/12 - 11:27 am
Ziopharm
palifosfamide
sarcoma
small cell lung cancer
US FDA rejects Merck/Ariad sarcoma drug
Reuters
Wed, 06/6/12 - 10:53 am
FDA
Merck
Ariad Pharmaceuticals
sarcoma
Taltorvic
Positive Vote for Glaxo's Votrient
Yahoo/Zacks
Sat, 03/24/12 - 11:35 am
GSK
Votrient
sarcoma
FDA panel recommends Glaxo's Votrient for sarcoma
Yahoo/Reuters
Wed, 03/21/12 - 10:02 am
FDA
advisory panel
Votrient
sarcoma
GSK
Threshold’s cancer drug gets Orphan Drug designation
Proactive Investors
Sat, 03/17/12 - 11:23 am
Threshold Pharmaceuticals
TH-302
sarcoma
Experts question Merck drug
Yahoo/Investors Business Daily
Sat, 03/17/12 - 10:54 am
Merck
Taltorvic
sarcoma
Threshold Pharmaceuticals and Merck KGaA Announce Global Agreement to Co-Develop and Commercialize Phase 3 Hypoxia-Targeted Drug TH-302
BioMedReports
Sat, 02/4/12 - 05:01 pm
Threshold Pharmaceuticals
Merck KGaA
TH-302
sarcoma
pancreatic cancer
Merck and Ariad say FDA will review application for their sarcoma pill ridaforolimus
Yahoo/AP
Wed, 10/5/11 - 10:52 am
FDA
sarcoma
ridaforolimus
Merck
Ariad Pharmaceuticals
Aethlon, Sarcoma Oncology Center to study hemopurifier in cancer patients
Wed, 08/24/11 - 09:15 pm
Aethlon Medical
sarcoma
study
Hemopurifier
cancer
Aethlon Medical Announces Sarcoma, Lung Cancer, Prostate Cancer, Metastatic Melanoma, and Head and Neck Cancer Studies
Wed, 08/24/11 - 09:03 pm
Aethlon Medical
sarcoma
lung cancer
prostate cancer
melanoma
cancer
Merck-Ariad Drug Under EU Review
Yahoo/Zacks
Sat, 08/20/11 - 10:00 pm
Merck
Ariad Pharmaceuticals
ridaforolimus
sarcoma
Ariad advances cancer drug, nabs $25M from partner Merck
Bizjournals.com
Thu, 08/18/11 - 05:35 pm
Ariad Pharmaceuticals
Merck
sarcoma
ridaforolimus
Ariad Gains Most in 18 Months on Cancer Drug Results
Bloomberg
Wed, 01/19/11 - 09:07 am
sarcoma
Ariad Pharmaceuticals
ridaforolimus
Ariad Sarcoma Drug Delays Progression
TheStreet.com
Tue, 01/18/11 - 10:47 am
Ariad Pharmaceuticals
sarcoma
ridaforolimus
Pages
1
2
next ›
last »